2020年后应用文献_技术支持_上海卓灏医药科技有限公司
上海卓灏医药科技有限公司
当前位置:网站首页 - 技术支持 - 应用文献  
2020年后应用文献

以下为部分代表性应用文章:

1. Liang-Yi Zhu, MS, Xiao-Yu Wu, MS, Xiao-Dan Liu, PhD, Dan-Feng Zheng, MD, Hai-Shuang Li, MS, Bao Yang, MD, Jing Zhang, MD, PhD, Qing Chang, MD, PhD, Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway, Journal of Neuropathology & Experimental Neurology, Volume 79, Issue 7, July 2020, Pages 734-745, https://doi.org/10.1093/jnen/nlaa041.

2. Jiajia Gao, Lusong Tian, Yulin Sun, Wei Li, Lina Zhao, Yan Sun, Zongpan Jing, Lanping Zhou, Fang Liu, Xiaohang Zhao. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2. Cancer Letters, Volume 498,2021,Pages 98-110,ISSN 0304-3835, https://doi.org/10.1016/j.canlet.2020.10.030.

3. Shuxuan Li, Fenglin Liu, Ling Xu, Can Li, Xu Yang, Bao Guo, Jianxin Gu and Lan Wang. Wnt/β-Catenin Signaling Axis Is Required for TFEB-Mediated Gastric Cancer Metastasis and EpithelialMesenchymal Transition. Mol Cancer Res November 1 2020 (18) (11) 1650-1659; DOI: 10.1158/1541-7786.MCR-20-0180.

4. Shusen Zhang, Yuanyuan Lu, Lei Qi, Hongyan Wang, Zhihua Wang, Zhigang Cai, AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma, BioMed Research International, vol. 2020, Article ID 8571932, 14 pages, 2020. https://doi.org/10.1155/2020/8571932.

5. Yu Sun, Sheng-Hua Li, Ji-Wen Cheng, Gang Chen, Zhi-Guang Huang, Yong-Yao Gu, Hai-Biao Yan, Mao-Lin He, "Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis", BioMed Research International, vol. 2020, Article ID 6037434, 17 pages, 2020. https://doi.org/10.1155/2020/6037434.

6. Wu, W, Zhao, Y, Gao, E, et al. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non–small cell lung cancer by sponging miR‐30a‐5p. J Cell Mol Med. 2020; 24: 441– 450. https://doi.org/10.1111/jcmm.14749.

7. Kong Jian, Yao Changyu, Ding Xuemei, Dong Shuying, Wu Shilun, Sun Wenbing, Zheng Lemin. ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy. Frontiers in Oncology. 2020(10) 1080. https://www.frontiersin.org/article/10.3389/fonc.2020.01080.

8. Mengge Li, Min Du, Hui Cong, Yuanyuan Gu, Yuan Fang, Jin Li, Yu Gan, Hong Tu, Jinyang Gu, Qiang Xia, Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma, Hepatology Research, 10.1111/hepr.13580, 0, 0, (2020).

9. Yang, Y., Lin, Z., Chen, J. et al. Autophagy in spinal ligament fibroblasts: evidence and possible implications for ossification of the posterior longitudinal ligament. J Orthop Surg Res 15, 490 (2020). https://doi.org/10.1186/s13018-020-02017-6.

10. Zhu T, Gao Z, Yuan K, Wang Y. High expression of RAD21 predicts poor survival in patients with operated non-small-cell lung cancer. Tumori Journal. 2020;106(3):223-228. doi:10.1177/0300891620910805.

11. Yang, Y, Lin, Z, Cheng, J, et al. The roles of autophagy in osteogenic differentiation in rat ligamentum fibroblasts: Evidence and possible implications. The FASEB Journal. 2020; 34: 8876– 8886. https://doi.org/10.1096/fj.201903216RR.

12. Junhui Xue, Zhengyi Cao, Yuning Cheng, Jiyin Wang, Yujuan Liu, Ruixiang Yang, Hui Li, Wei Jiang, Gang Li, Wenhui Zhao, Xiaowei Zhang, Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression, Cancer Letters,Volume 471,2020, Pages 12-26, https://doi.org/10.1016/j.canlet.2019.11.043.

13. Chen, T., Dai, X., Dai, J. et al. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death Dis 11, 822 (2020). https://doi.org/10.1038/s41419-020-03030-7.

14. Zhang, J., Xiao, C., Feng, Z. et al. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell Int 20, 468 (2020). https://doi.org/10.1186/s12935-020-01568-2.

15. Song, Y., Wang, M., Tong, H. et al. Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression. Oncogene (2020). https://doi.org/10.1038/s41388-020-01555-x.

16. Hou Y, Wang W, Zeng Z, et al. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma. Aging (Albany NY). 2020;12(21):21992-22018. doi:10.18632/aging.104038.

17. Zhou, Y., Liu, F., Xu, Q. et al. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer. Oncogene 39, 5633–5648 (2020). https://doi.org/10.1038/s41388-020-1384-3.

18. Zhou, Lijie & Zhengshuai, & Song, & Hu, Junyi & Liu, Lilong & Zhang, Xiaoping & Yang, Xiong & Chen, Ke. (2021). ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3. Theranostics. 11. 841-860. 10.7150/thno.49384.

19. Xie, P., Peng, Z., Chen, Y. et al. Neddylation of PTEN regulates its nuclear import and promotes tumor development. Cell Res (2020). https://doi.org/10.1038/s41422-020-00443-z.

20.Li, Y., Deng, Y., Zhao, Y. et al. Immunoglobulin superfamily 9 (IGSF9) is trans-activated by p53, inhibits breast cancer metastasis via FAK. Oncogene (2022). https://doi.org/10.1038/s41388-022-02459-8.

21.Wu Y, Yi Z, Li J, Wei Y, Feng R, Liu J, Huang J, Chen Y, Wang X, Sun J, Yin X, Li Y, Wan J, Zhang L, Huang J, Du H, Wang X, Li Q, Ren G, Li H. FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts. Theranostics. 2022 May 27;12(10):4564-4580. doi: 10.7150/thno.68972. PMID: 35832090; PMCID: PMC9254240.

22.Chen T Y, Yang C Y, Yang M T, et al. Protein disulfide isomerase a4 promotes lung cancer development via the Stat3 pathway in stromal cells[J]. Clinical and Translational Medicine, 2022, 12(2): e606.

23.Zhang Z, Fan W, Gao Q, et al. Hsa_Circ_0000826 inhibits the proliferation of colorectal cancer by targeting AUF1[J]. Journal of Genetics and Genomics, 2022.

24.Wang J, Shao F, Yang Y, et al. A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability[J]. Cancer Communications, 2022.

25.Zhao Y, Xie X, Tian L, et al. MARCKSL1 interacted with F‐actin to promote esophageal squamous cell carcinoma mobility by modulating the formation of invadopodia[J]. Cancer Medicine, 2022.

26.Li L, Yu S, Chen J, et al. miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation[J]. Cell Death Discovery, 2022, 8(1): 1-11.

27.Zhang Y, Guo L, Dai Q, et al. A signature for pan-cancer prognosis based on neutrophil extracellular traps. Journal for ImmunoTherapy of Cancer2022;10:e004210. doi:10.1136/jitc-2021-004210.

28.Tong X, Xiang Y, Hu Y, et al. NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma[J]. Frontiers in oncology, 2022, 12.

29.Li, Xin-yang, et al. "A Microarray Study on the Expression of ANKRD49 in Lung Squamous Cell Carcinoma and Its Clinicopathologic Significance." Applied Immunohistochemistry & Molecular Morphology: 10-1097.

30.Wang M, Sun X, Xin H, et al. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma[J]. Cancer Medicine, 2022.

31.Fan M, Gao J, Zhou L, et al. Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer[J]. Acta Pharmaceutica Sinica B, 2022.

32.Wang X, Ma L, Pei X, et al. Comprehensive assessment of cellular senescence in the tumor microenvironment[J]. Briefings in Bioinformatics, 2022.

33.Xie B, Tan G, Ren J, et al. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer[J]. Frontiers in oncology, 2022, 12.

34.Fan Y, Zhou Y, Li X, et al. Long Non-Coding RNA AL513318. 2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer[J]. Frontiers in oncology, 2022, 12.

35.Wang J, Zheng H, He H, et al. TPX2 Serves as a Cancer Susceptibility Gene and Is Closely Associated with the Poor Prognosis of Endometrial Cancer[J]. Genetics Research, 2022, 2022.

36.Zhu L, Yang Y, Li H, et al. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma[J]. Cancer Letters, 2022: 215630.

37.Zhou Y, Fan Y, Mao Y, et al. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer[J]. Biomarkers in Medicine, 2022 (0).

38.Tian Y, Zhou Y, Liu J, et al. Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer[J]. International Journal of General Medicine, 2022, 15: 803.

39.Huang W, Huang H, Xiao Y, et al. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer[J]. Cell Cycle, 2022: 1-12.

       40.Xue, W., Li, X., Li, W. et al. Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic            reprogramming in breast cancer. Sig Transduct Target Ther 7, 35 (2022). https://doi.org/10.1038/s41392-021-00856-1.

     41.Liao P, Huang W, Cao L, et al. Low expression of FOXP2 predicts poor survival and targets caspase-1 to inhibit cell pyroptosis in colorectal cancer[J]. Journal of Cancer, 2022, 13(4): 1181-1192.

     42.Xu H, Yan X, Zhu H, et al. TBL1X and Flot2 form a positive feedback loop to promote metastasis in nasopharyngeal carcinoma[J]. International Journal of Biological Sciences, 2022, 18(3): 1134-1149.

      43.Zhang L, Wang W, Liu L, et al. PGC‐1α protects a fibrotic liver from partial hepatectomy‐induced advanced liver injury through regulating cell cycle arrest[J]. Basic & Clinical Pharmacology & Toxicology, 2021.

      44.Huang T, Wu Q, Huang H, et al. Expression of GALNT8 and O-glycosylation of BMP receptor 1A suppress breast cancer cell proliferation by upregulating ERα levels[J]. Biochimica et Biophysica Acta (BBA)-General Subjects, 2021: 130046.

    45.Bai X, Ni J, Beretov J, et al. THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer[J]. Advanced Science, 2021: 2102658.

      46.Zhang W, Pan R, Lu M, et al. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway[J]. Oncogene, 2021: 1-12.

     47.Li L, Liu J, Huang W. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription[J]. Digestive and Liver Disease, 2021.

     48.Min Zhu, Zi Liang, Jun Pan, Xing Zhang, Renyu Xue, Guangli Cao, Xiaolong Hu, Chengliang Gong, Hepatocellular carcinoma progression mediated by hepatitis B virus-encoded circRNA HBV_circ_1 through interaction with CDK1, Molecular Therapy - Nucleic Acids, Volume 25, 2021, Pages 668-682, ISSN 2162-2531, https://doi.org/10.1016/j.omtn.2021.08.011.

      49.Jiang, Y., Yuan, Y., Chen, M., Li, S., Bai, J., Zhang, Y., Sun, Y., Wang, G., Xu, H., Wang, Z., Zheng, Y., & Nie, H. (2021). PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics, 11(18), 9162–9176. https://doi.org/10.7150/thno.59605.

      50.Zhang, Xuerui, et al. "ANXA10 promotes melanoma metastasis by suppressing E3 ligase TRIM41-directed PKD1 degradation." Cancer Letters (2021).

      51.Wang L, Liu Z, Liu L, et al. CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis[J]. Journal of Cellular and Molecular Medicine, 2021.

      52.Dong, Yanqi, et al. "OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression." Oncology Letters 22.2 (2021): 1-13.
53.Yang H, Xie S, Liang B, et al. Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil[J]. Journal of Cancer, 2021, 12(16): 4862-4872.

    54.Zongpan Jing, Jiajia Gao, Jun Li, Fangfei Niu, Lusong Tian, Peng Nan, Yan Sun, Xiufeng Xie, Ying Zhu, Yan Zhao, Fang Liu, Lanping Zhou, Yulin Sun, Xiaohang Zhao,Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy,Cancer Letters,Volume 519,2021,Pages 46-62,ISSN 0304-3835. https://doi.org/10.1016/j.canlet.2021.06.016.

   55.Yang Y ,  Fan X ,  Nie Y , et al. CircTUBGCP3 facilitates the tumorigenesis of lung adenocarcinoma by sponging miR-885-3p.  2021.doi: https://doi.org/10.21203/rs.3.rs-502804/v1.

   56.Jin D, Huang K, Peng L, Xu P, Dang Y, Yang J, Chen M, Zhu X, Wei S, Yan J, Zhang G, Circular RNA circDNA2 upregulates CCDC6 expression to promote the progression and unfavorable prognosis of gastric cancer via miR-149-5p suppression, Molecular Therapy: Nucleic Acid(2021), doi: https://doi.org/10.1016/j.omtn.2021.05.021.

   57.Li J, Tian L, Jing Z, et al. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis[J]. Cancer Letters, 2021.

   58.Yazhou Wang, Huahu Guo, Zhengkui Zhang, Qi Wang, Xiaodong Tian, Yinmo Yang. Inhibition of bone morphogenetic protein receptor 2 suppresses pancreatic ductal adenocarcinoma growth by regulating GRB2/PI3K/AKT axis.Ann Transl Med 2021;9(7):557. http://dx.doi.org/10.21037/atm-20-2194.

  59.Zhao Y, Gao J, Xie X, Nan P, Liu F, Sun Y, Zhao X. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis. Cancer Med. 2021 May 1. doi: 10.1002/cam4.3884. Epub ahead of print. PMID: 33932125.

   60.Cao Z, Cheng Y, Wang J, et al. HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression[J]. Journal of Experimental & Clinical Cancer Research, 2021, 40(1): 1-20.

   61.Zhang B, Wang H Y, Zhao D X, et al. hnRNPU Functions as a Novel Therapeutic Target of c-Myc in the Progression of Hepatocellular Carcinoma[J]. FEBS Letters, 2020.

  62.Liu J, Tian Y, Yi L, Gao Z, Lou M, Yuan K. High KIF11 expression is associated with poor outcome of NSCLC. Tumori Journal. February 2021. doi:10.1177/0300891620988342.

  63.Dong, YiMin; Sun, Jia; Li(2020). Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia. Clinical Infectious Diseases, (), ciaa963. doi:10.1093/cid/ciaa963.

  64. Liu J, Tian Y, Yi L, Gao Z, Lou M, Yuan K. High KIF11 expression is associated with poor outcome of NSCLC. Tumori Journal. February 2021. doi:10.1177/0300891620988342.

  65. Liu, Zhuohang; Li, Hang Twisted gastrulation signaling modulator 1 promotes the ability of glioma cell through activating Akt pathway, NeuroReport: February 3, 2021 - Volume 32 - Issue 3 - p 198-205 doi: 10.1097/WNR.0000000000001581.

  66. Fan, G., Sun, L., Meng, L. et al. The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation. Nat Commun 12, 20 (2021). https://doi.org/10.1038/s41467-020-20208-x.

  67. Hang, C., Zhao, S., Wang, T. et al. Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling. Cancer Cell Int 21, 25 (2021). https://doi.org/10.1186/s12935-020-01733-7.

 68. Li Chao, Ao Hongfeng, Chen Guofang, Wang Fang, Li Fang. The Interaction of CDH20 With β-Catenin Inhibits Cervical Cancer Cell Migration and Invasion via TGF-β/Smad/SNAIL Mediated EMT. Frontiers in Oncology. 2020;9:1481. doi:10.3389/fonc.2019.01481.

  69. Tong H, Feng H, Hu X, et al. Identification of Interleukin-9 Producing Immune Cells in Endometrial Carcinoma and Establishment of a Prognostic Nomogram. Front Immunol. 2020;11:544248. Published 2020 Nov 19. doi:10.3389/fimmu.2020.544248.

  70.Song, Y., Wang, M., Tong, H., Tan, Y., Hu, X., Wang, K., & Wan, X. (2020). Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression. Oncogene. doi:10.1038/s41388-020-01555-x .

   71.Hou Y, Wang W, Zeng Z, Gan W, Lv S, Li T, Yan Z, Zhang R, Yang M. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma. Aging (Albany NY). 2020 Nov 7;12(21):21992-22018. doi: 10.18632/aging.104038.

  72.Gao, J., Tian, L., Sun, Y., Li, W., Zhao, L., Sun, Y., … Zhao, X. (2020). PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2. Cancer Letters. doi:10.1016/j.canlet.2020.10.030 .

  73.Zhou L, Song Z, Hu J, Liu L, Hou Y, Zhang X, Yang X, Chen K. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3. Theranostics 2021; 11(2):841-860. doi:10.7150/thno.49384.

  74.Yu, S, Ao, Z, Wu, Y, et al. ZNF300 promotes chemoresistance and aggressive behaviour in non‐small‐cell lung cancer. Cell Prolif 2020; 00:e12924. https://doi.org/10.1111/cpr.12924.

  75.Chen et al. Cell Death and Disease (2020)11:822. https://doi.org/10.1038/s41419-020-03030-7.

  76.Song Chen, Qiang Zhou, Tongzu Liu, Weibing Zhang, Xian-Tao Zeng, Zhongqiang Guo, J. Cancer 2020; 11(5): 1212-1222. doi: 10.7150/jca.38283.
        77.Georgia Rose, Kafer, Xuan, et al. 5-Hydroxymethylcytosine Marks Sites of DNA Damage and Promotes Genome Stability[J]. Cell Reports, 2016. https://doi.org/10.1016/j.celrep.2016.01.035.

  78.Shuxuan Li, Fenglin Liu, Ling Xu, Can Li, Xu Yang, Bao Guo, Jianxin Gu and Lan Wang. Wnt/β-catenin signaling axis is required for TFEB-mediated gastric cancermetastasis and epithelial-mesenchymal transition.2020 Aug 4;molcanres.0180.2020.doi: 10.1158/1541-7786.MCR-20-0180.

 79.Zhou, Y., Liu, F., Xu, Q. et al. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer. Oncogene (2020). https://doi.org/10.1038/s41388-020-1384-3

 80.Kong J, Yao C, Ding X, Dong S, Wu S,Sun W and Zheng L (2020) ATPaseInhibitory Factor 1 PromotesHepatocellular Carcinoma ProgressionAfter Insuffificient RadiofrequencyAblation, and Attenuates CellSensitivity to Sorafenib Therapy.Front. Oncol. 10:1080.doi: 10.3389/fonc.2020.01080.

 81.Li M, Shen Y, Chen Y, et al.Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma. Int. J. Cancer. 2020; 1–11. https://doi.org/10.1002/ijc.33027.

 82.Qing Chang, Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway , J Neuropathol Exp Neurol.Vol. 0, No. 0, 2020, pp. 1–12. DOI: 10.1093/jnen/nlaa041.

 83.Jianye Xu,Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κBactivation , Journal of Experimental & Clinical Cancer Research (2020) 39:59.https://doi.org/10.1186/s13046-020-01553-7.

  84.Weiming Wu, LncRNA DLEU2 accelerates the tumorigenesis and invasion of non–small cell lung cancer by sponging miR‐30a‐5p, J Cell Mol Med. 2020 Jan;24(1):441-450. doi: 10.1111/jcmm.14749. Epub 2019 Nov 13.

85.Chun Lan Kang,LncRNA AY promoteshepatocellular carcinoma metastasis by stimulating ITGAV transcription,Theranostics. 2019 Jun 9;9(15):4421-4436.doi: 10.7150/thno.32854.

86.Li-ming Liu, Methylation of C/EBPα by PRMT1 inhibits its tumor suppressive function in breast cancer. Cancer Research. DOI: 10.1158/0008-5472.CAN-18-3211.

87.ChongChen, Targeting LIN28B reprograms tumor glucose metabolism and acidicmicroenvironment to suppress cancer stemness and metastasis. Oncogene. 2019Jun;38(23):4527-4539. doi: 10.1038/s41388-019-0735-4.

88.Junhui Xue, Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression, Cancer Letters, 2020 Feb 28;471:12-26. doi: 10.1016/j.canlet.2019.11.043.
89.Wang Y, Weng X, Wang L, et al. HIC1deletion promotes breast cancer progression by activating tumor cell/fibroblastcrosstalk. J Clin Invest 2018; doi: 10.1172/JCI99974.

90.F. Song, Q. Chen, W. Rao, et al., OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling,EBIOM-01983; https://doi.org/10.1016/j.ebiom.2019.02.051.

91.Hui Liu,Circular RNA YAP1inhibits the proliferation and invasion of gastric cancer cells by regulatingthe miR-367-5p/p27 Kip1 axis,Molecular Cancer,2018; 17:151. DOI 10.1186/s12943-018-0902-1.

文章列表请参考以下文件:部分文章列表.xlsx


您可能感兴趣的同类信息

  2020年后应用文献   组织芯片
  PCR芯片   蛋白芯片   细胞
  组织   血清血浆   RNA
  高通量测序样品制备要求   石蜡标本
地址:上海市徐汇区漕溪路125弄15号皇家大厦4F 电话:021-64175203 4008215712
邮箱:472380328@qq.com 版权所有 上海卓灏医药科技有限公司   技术支持:绿飞扬
沪ICP备16046846号-1